Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT)
Abstract
The overarching goal of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program is to increase our ability to rapidly respond to a disease or threat and improve individual readiness and total force health protection by providing centralized laboratory capabilities at non-tertiary care settings. ADEPT will focus on the development of Ribonucleic Acid (RNA)-based vaccines, potentially eliminating the time and labor required for traditional manufacture of a vaccine while at the same time improving efficacy. Additionally, ADEPT will develop methods to transiently deliver nucleic acids for vaccines and therapeutics, and kinetically control the timing and levels of gene expression so that these drugs will be safe and effective for use in healthy subjects. ADEPT will also focus on advanced development of key elements for simple-to-operate diagnostic devices. A companion basic research effort is budgeted in PE 0601117E, Project MED-01.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2017
- Source ID
- 6f08401947833d0d06d79093333a1a3a
Related Documents
- Root: BIOMEDICAL TECHNOLOGY